Home ›
Trademark Categories ›
Pharmaceuticals ›
2011 ›
SE ›
SESSORI
Trademark search for:
SESSORI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2011-06-28 — Application filed
2011-07-01 — Application filed
2011-07-05 — Application filed
2011-08-25 — Assigned to examiner
2011-08-26 — Approved for pub - principal register
2011-08-26 — Assigned to lie
2011-08-30 — Law office publication review completed
2011-10-04 — Published for opposition
2011-10-04 — Official gazette publication confirmation e-mailed
2011-10-04 — Official gazette publication confirmation e-mailed
2011-11-29 — Noa e-mailed - sou required from applicant
2012-05-29 — Sou extension 1 filed
2012-06-21 — Sou extension received with teas petition
2012-06-21 — Notice of revival - e-mailed
2012-06-21 — Petition to revive-granted
2012-06-21 — Teas petition to revive received
2012-07-18 — Case assigned to intent to use paralegal
2012-07-18 — Sou extension 1 granted
2012-07-19 — Notice of approval of extension request e-mailed
2012-11-29 — Sou teas extension received
2012-11-29 — Sou extension 2 filed
2012-12-05 — Sou extension 2 granted
2012-12-06 — Notice of approval of extension request e-mailed
2013-07-01 — Application abandoned
2013-07-01 — Application abandoned
2013-07-01 — Final status recorded
Owner Information
Noven Pharmaceuticals, Inc.
Miami , FL
Noven Pharmaceuticals, Inc.
Miami , FL
Correspondent
JAY G. KOLMAN NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH ST MIAMI, FL 33186-6109 UNITED STATES
Filing Details
Filing Date:
2011-06-28
Status Date:
2013-07-01
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.